v.novak
Submits third-party assay reports on material purchased directly. Based in Konya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.40%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042926 | Semaglutide | MKM | MKM-2508-R2718 | Kestrel | 2026-Q1 | 99.41 | 5.66 | 100.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042413 | Semaglutide | SWB | SWB-2602-W5529 | VendorInvestigate | 2026-Q1 | 98.41 | 5.62 | 90.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020080 | Semaglutide | ERP | ERP-2509-A8587 | Nordanalyt | 2025-Q4 | 98.20 | 5.65 | 91.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021247 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | Janoshik | 2025-Q3 | 97.71 | 6.50 | 100.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-020071 | Retatrutide | ERP | ERP-2507-P8449 | Janoshik | 2025-Q3 | 98.53 | 1.68 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018646 | N-Acetyl Semax Amide | QYB | QYB-2411-G5768 | Janoshik | 2025-Q2 | 99.34 | 9.46 | 95.9 | Supplier-supplied | 0 | PASS |
| AX-2025-019705 | Tirzepatide | HJ | HJ-2501-P2892 | Nordanalyt | 2025-Q1 | 98.14 | 2.52 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004165 | Tirzepatide | WWB | WWB-2403-J3152 | PeptideMeter | 2024-Q3 | 98.39 | 3.71 | — | Supplier-supplied | 2 | MARGINAL |